Osteoporosis Overview and Treatment
27 Questions
12 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is one of the major risks associated with Hormone Replacement Therapy (HRT)?

  • Improved cardiovascular health
  • Cerebrovascular accidents (correct)
  • Osteoporotic fractures
  • Increased bone density
  • What is the primary action of HRT in postmenopausal patients?

  • Increasing blood circulation
  • Enhancing calcium absorption
  • Inhibiting bone resorption (correct)
  • Stimulating osteoblast activity
  • Which of the following is contraindicated for patients considering HRT?

  • History of venous thromboembolism (correct)
  • History of osteopenia
  • Low estrogen levels
  • Age over 50
  • What is a specific recommendation for prescribing HRT?

    <p>Prescribe at the lowest effective dose</p> Signup and view all the answers

    What does the Black Box Warning for HRT indicate?

    <p>Significant risks like endometrial cancer and dementia</p> Signup and view all the answers

    What is the primary cause of primary osteoporosis?

    <p>Age-related bone loss</p> Signup and view all the answers

    Which of the following treatments is commonly used to prevent fragility fractures in osteoporosis?

    <p>Bisphosphonates</p> Signup and view all the answers

    What condition is NOT typically associated with secondary osteoporosis?

    <p>Physical inactivity</p> Signup and view all the answers

    What is the recommended duration for pharmacologic treatment with bisphosphonates?

    <p>Five years</p> Signup and view all the answers

    Why is it suggested to take a drug holiday after five years of bisphosphonate treatment?

    <p>To decrease the risk of atypical fractures</p> Signup and view all the answers

    Which of the following factors is not considered when treating women 65 years and older with osteopenia?

    <p>Socioeconomic status</p> Signup and view all the answers

    What does dual-energy x-ray absorptiometry (DEXA) primarily measure in osteoporosis diagnosis?

    <p>Bone mineral density (BMD)</p> Signup and view all the answers

    Which of the following pharmacologic treatments is specifically indicated for postmenopausal women?

    <p>Selective estrogen receptor modulators</p> Signup and view all the answers

    What is the primary goal of pharmacologic therapy in preventing osteoporosis?

    <p>To reduce risk of fractures</p> Signup and view all the answers

    Which medication type inhibits osteoclast activity and decreases bone resorption?

    <p>Antiresorptive drugs</p> Signup and view all the answers

    What is a common side effect associated with bisphosphonates?

    <p>Esophageal irritation</p> Signup and view all the answers

    What must be monitored before initiating bisphosphonate treatment?

    <p>Calcium and kidney function</p> Signup and view all the answers

    How often is Denosumab administered?

    <p>Every six months</p> Signup and view all the answers

    What is a primary risk factor associated with the use of selective estrogen receptor modulators (SERMs)?

    <p>Deep vein thrombosis</p> Signup and view all the answers

    Which medication promotes bone formation and is reserved for high-risk fracture patients?

    <p>Teriparatide</p> Signup and view all the answers

    What factor can contraindicate the use of oral bisphosphonates?

    <p>Esophageal motility disorders</p> Signup and view all the answers

    What is a common effect of SERMs in relation to breast cancer?

    <p>Lower the risk of breast cancer</p> Signup and view all the answers

    Which of the following is NOT a component of preventive strategies for osteoporosis?

    <p>Excessive caffeine intake</p> Signup and view all the answers

    What is the maximum recommended daily intake of calcium for most adults?

    <p>1200-1500 mg</p> Signup and view all the answers

    Which medication works by binding to RANKL to inhibit osteoclasts?

    <p>Denosumab</p> Signup and view all the answers

    Which statement regarding hormone replacement therapy (HRT) is true?

    <p>It must be assessed on an individual case basis.</p> Signup and view all the answers

    What is a common side effect of teriparatide?

    <p>Joint pain</p> Signup and view all the answers

    Study Notes

    Osteoporosis Overview

    • Osteoporosis increases risk of fragility fractures, most commonly in hips, spine, and wrists.
    • Diagnosis aided by fragility fractures and low bone mineral density (BMD), determined by DEXA scans.
    • Treatment targets bone resorption; includes bisphosphonates, peptide hormones, calcium, vitamin D, estrogen, and SERMs.
    • Bisphosphonates effective in reducing vertebral, non-vertebral, and hip fractures, recommended for postmenopausal women.
    • Calcium and vitamin D supplements may also be used but fracture prevention effectiveness is uncertain.

    Types of Osteoporosis

    • Primary osteoporosis: age-related bone loss.
    • Secondary osteoporosis: medication- or disease-induced (e.g., chronic steroids, androgen deficiency, hypogonadism, anorexia/bulimia, celiac disease, hyperthyroidism, ankylosing spondylitis).

    Pharmacologic Treatment

    • Bisphosphonate treatment duration: typically 5 years.
    • Benefits may extend beyond 5 years; ongoing treatment should be considered after weighing risks and benefits.
    • Drug holidays may be recommended for extended treatment (>5 years) to mitigate atypical fracture risk.
    • Bone density monitoring during 5 years of treatment isn't necessary.
    • Consider treatment for osteopenia in high-risk patients (age 65+).
    • Bisphosphonates recommended for men with osteoporosis to reduce vertebral fracture risk.

    Preventive Strategies

    • Diet high in calcium, regular bone-strengthening exercises.
    • Daily calcium (1200-1500mg) and vitamin D (800-1000 IU) supplementation as needed.
    • Reduce modifiable risk factors like smoking, excessive alcohol, high caffeine, low calcium&vitamin D, and physical inactivity.

    Types of Medications for Osteoporosis

    • Antiresorptive drugs: decrease osteoclast activity (e.g., bisphosphonates, hormones, SERMs, RANKL inhibitors).
    • Parathyroid hormone analogs: stimulate osteoblast function (e.g., teriparatide).

    Bisphosphonates

    • Mechanism of action: structural analogs of pyrophosphate, incorporated into bone, inhibit osteoclast activity.
    • Recommended for postmenopausal patients at high fracture risk.
    • Five-year treatment duration is standard; benefits often last longer.
    • Crucial to screen for low serum calcium and sufficient kidney function before treatment.
    • Supplement with calcium and vitamin D for maximum effect.
    • Possible side effects: upper GI tract irritation (esophagus), atypical femur fractures, esophageal cancer, and jaw osteonecrosis.
    • Contraindications: inability to sit upright, esophageal motility disorders, or severe renal dysfunction.

    Monoclonal Antibody/RANKL Inhibitor (Denosumab)

    • Mechanism of action: inhibits osteoclast formation, function, and survival, decreasing bone resorption.
    • Administered via injection every six months.
    • Potential side effects: serious infections, skin reactions, musculoskeletal pain, atypical femur fractures, hypocalcemia.

    Parathyroid Hormone Analogs (Teriparatide)

    • Mechanism of action: stimulates osteoblast function, increases calcium absorption and reabsorption.
    • Increases skeletal mass and strength.
    • Approved for 2 years; safety beyond that is unclear.
    • Reserved for severe cases with a high fracture risk.

    Selective Estrogen Receptor Modulators (SERMs)

    • Mechanism of action: bind to estrogen receptors, reducing osteoclast activity and potentially breast cancer risk.
    • Alternative for patients unsuitable for bisphosphonates or denosumab, those at high fracture risk with a high breast cancer risk.
    • Risk of deep vein thrombosis.
    • May be less effective than bisphosphonates and teriparatide, possibly increasing venous thromboembolism risk particularly early in treatment.
    • Black box warning for thromboembolic events.
    • Contraindicated for patients with previous venous thromboembolic disorders or risk.

    Hormone Replacement Therapy (HRT)

    • Mechanism of action: inhibits osteoclast-driven bone resorption.
    • Use depends on individual patient's benefit/risk; review risks (e.g., stroke, blood clots, breast cancer).
    • May reduce fractures in postmenopausal patients.
    • Use at lowest effective dose and shortest duration.
    • High-risk side effects: stroke, blood clots, breast cancer.
    • Contraindicated with a history of venous thromboembolism.
    • Black box warning: endometrial cancer, cardiovascular disease, breast cancer, and dementia.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the key aspects of osteoporosis, including its types, diagnosis, and treatment options. Learn about the role of bisphosphonates, calcium, and vitamin D in managing this condition. Understand the differences between primary and secondary osteoporosis along with important treatment guidelines.

    More Like This

    Medicine and Physiotherapy
    8 questions

    Medicine and Physiotherapy

    SolicitousBurgundy avatar
    SolicitousBurgundy
    Osteoporosis Medications Quiz
    10 questions
    Drug List #10 - Osteoporosis Medications
    10 questions
    Use Quizgecko on...
    Browser
    Browser